{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T17:27:29Z","timestamp":1764782849280},"reference-count":29,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2004,9,1]],"date-time":"2004-09-01T00:00:00Z","timestamp":1093996800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2004,9]]},"DOI":"10.1016\/j.clim.2004.04.010","type":"journal-article","created":{"date-parts":[[2004,6,9]],"date-time":"2004-06-09T20:56:45Z","timestamp":1086814605000},"page":"268-272","source":"Crossref","is-referenced-by-count":33,"title":["Profile of autoantibody to basement membrane zone proteins in patients with mucous membrane pemphigoid: long-term follow up and influence of therapy"],"prefix":"10.1016","volume":"112","author":[{"given":"Shih Wei","family":"Yeh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adnan Q","family":"Usman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.Razzaque","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clim.2004.04.010_BIB1","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S1079-2104(99)70194-0","article-title":"Update on mucous membrane pemphigoid: a heterogeneous immune-mediated subepithelial blistering entity","volume":"88","author":"Scully","year":"1999","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endo."},{"key":"10.1016\/j.clim.2004.04.010_BIB2","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1067\/mjd.2000.107248","article-title":"Cicatricial pemphigoid","volume":"43","author":"Fleming","year":"2000","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.clim.2004.04.010_BIB3","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/1523-1747.ep12275033","article-title":"Localization of basement membrane components in mucous membrane pemphigoid","volume":"84","author":"Meyer","year":"1985","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.clim.2004.04.010_BIB4","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/S1079-2104(99)70056-9","article-title":"Contemporary issues in the diagnosis of oral pemphigoid: a selective review of the literature","volume":"88","author":"Dayan","year":"1999","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endo."},{"key":"10.1016\/j.clim.2004.04.010_BIB5","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/S0025-7125(05)70415-6","article-title":"The blistering diseases","volume":"82","author":"Scott","year":"1998","journal-title":"Med. Clin. North Am."},{"key":"10.1016\/j.clim.2004.04.010_BIB6","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1001\/archderm.138.3.380","article-title":"Interventions for mucous membrane pemphigoid\/cicatricial pemphigoid and epidermolysis bullosa acquisita: a systematic literature review","volume":"138","author":"Kirtschig","year":"2002","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.clim.2004.04.010_BIB7","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1023\/A:1026451530967","article-title":"Autoantibodies to type VII collagen have heterogeneous subclass and light chain compositions and their complement-activating capacities do not correlate with the inflammatory clinical phenotype","volume":"20","author":"Gandhi","year":"2000","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.clim.2004.04.010_BIB8","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1034\/j.1600-0625.2000.009004271.x","article-title":"Bovine gingival lysate: a novel substrate for rapid diagnosis of autoimmune vesiculo-bullous diseases. A preliminary observation","volume":"9","author":"Engineer","year":"2000","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.clim.2004.04.010_BIB9","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1046\/j.1365-2133.2001.04543.x","article-title":"Cicatricial pemphigoid with circulating autoantibodies to beta4 integrin, bullous pemphigoid 180 and bullous pemphigoid 230","volume":"145","author":"Leverkus","year":"2001","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.clim.2004.04.010_BIB10","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1006\/clim.2001.5091","article-title":"IgG autoantibodies in patients with anti-epiligrin cicatricial pemphigoid recognize the G domain of the laminin 5 alpha-subunit","volume":"101","author":"Lazarova","year":"2001","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.clim.2004.04.010_BIB11","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/1523-1747.ep12298424","article-title":"Identification of a 168-kDa mucosal antigen in a subset of patients with cicatricial pemphigoid","volume":"107","author":"Ghohestani","year":"1996","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.clim.2004.04.010_BIB12","doi-asserted-by":"crossref","first-page":"14714","DOI":"10.1073\/pnas.93.25.14714","article-title":"Ocular cicatricial pemphigoid antigen: partial sequence and biochemical characterization","volume":"93","author":"Tyagi","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.clim.2004.04.010_BIB13","first-page":"379","article-title":"Identification of ocular cicatricial pemphigoid antibody binding site(s) in human beta4 integrin","volume":"42","author":"Kumari","year":"2001","journal-title":"Invest. Ophthalmol. Visual Sci."},{"key":"10.1016\/j.clim.2004.04.010_BIB14","first-page":"2283","article-title":"The role of antibody to human beta4 integrin in conjunctival basement membrane separation: possible in vitro model for ocular cicatricial pemphigoid","volume":"40","author":"Chan","year":"1999","journal-title":"Invest. Ophthalmol. Visual Sci."},{"key":"10.1016\/j.clim.2004.04.010_BIB15","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1046\/j.1523-1747.2003.12081.x","article-title":"Autoantibody in mucous membrane pemphigoid binds to an intracellular epitope on human beta4 integrin and causes basement membrane zone separation in oral mucosa in an organ culture model","volume":"120","author":"Bhol","year":"2003","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.clim.2004.04.010_BIB16","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0161-6420(01)00863-6","article-title":"The effect of treatment and its related side effects in patients with severe ocular cicatricial pemphigoid","volume":"109","author":"Miserocchi","year":"2002","journal-title":"Ophthalmology"},{"key":"10.1016\/j.clim.2004.04.010_BIB17","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1016\/S0161-6420(99)90496-7","article-title":"Intravenous immunoglobulin therapy for ocular cicatricial pemphigoid: a preliminary study","volume":"106","author":"Foster","year":"1999","journal-title":"Ophthalmology"},{"key":"10.1016\/j.clim.2004.04.010_BIB18","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1006\/clim.2001.5150","article-title":"Intravenous immunoglobulin therapy in patients with multiple mucosal involvement in mucous membrane pemphigoid","volume":"102","author":"Sami","year":"2002","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.clim.2004.04.010_BIB19","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1076\/0271-3683(200008)2121-VFT646","article-title":"Influence of intravenous immunoglobulin therapy on serum levels of anti-beta 4 antibodies in ocular cicatricial pemphigoid. A correlation with disease activity. A preliminary study","volume":"21","author":"Letko","year":"2000","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.clim.2004.04.010_BIB20","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.4049\/jimmunol.165.5.2824","article-title":"The autoantibodies to alpha 6 beta 4 integrin of patients affected by ocular cicatricial pemphigoid recognize predominantly epitopes within the large cytoplasmic domain of human beta 4","volume":"165","author":"Bhol","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2004.04.010_BIB21","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1177\/00220345010800080601","article-title":"Autoantibodies to human alpha6 integrin in patients with oral pemphigoid","volume":"80","author":"Bhol","year":"2001","journal-title":"J. Dent. Res."},{"key":"10.1016\/j.clim.2004.04.010_BIB22","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/1523-1747.ep12329728","article-title":"Cicatricial pemphigoid autoantibodies react with multiple sites on the BP180 extracellular domain","volume":"106","author":"Balding","year":"1996","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.clim.2004.04.010_BIB23","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1006\/clim.2000.4972","article-title":"In vitro organ culture model for mucous membrane pemphigoid","volume":"98","author":"Colon","year":"2001","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.clim.2004.04.010_BIB24","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1001\/archderm.130.12.1521","article-title":"Antiepiligrin cicatricial pemphigoid. A subepithelial bullous disorder","volume":"130","author":"Domloge-Hultsch","year":"1994","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.clim.2004.04.010_BIB25","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1046\/j.1468-3083.2003.00714.x","article-title":"Influence of intravenous immunoglobulin therapy on autoantibody titres to BP Ag1 and BP Ag2 in patients with bullous pemphigoid","volume":"17","author":"Sami","year":"2003","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.clim.2004.04.010_BIB26","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1006\/clim.2002.5278","article-title":"Influence of IVIg therapy on autoantibody titers to desmoglein 1 in patients with pemphigus foliaceus","volume":"105","author":"Sami","year":"2002","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.clim.2004.04.010_BIB27","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1046\/j.1365-2249.2002.01967.x","article-title":"High-dose intravenous immunoglobulin (hdIVIg) in the treatment of autoimmune blistering disorders","volume":"129","author":"Jolles","year":"2002","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.clim.2004.04.010_BIB28","first-page":"713","article-title":"Intravenous immunoglobulin: an emerging treatment for immune-mediated skin diseases","volume":"3","author":"Rutter","year":"2002","journal-title":"Curr. Opin. Invest. Drugs"},{"key":"10.1016\/j.clim.2004.04.010_BIB29","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/S0923-1811(02)00109-3","article-title":"BP180 ELISA using bacterial recombinant NC16a protein as a diagnostic and monitoring tool for bullous pemphigoid","volume":"30","author":"Kobayashi","year":"2002","journal-title":"J. Dermatol. Sci."}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661604001238?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661604001238?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,7]],"date-time":"2019-02-07T08:52:26Z","timestamp":1549529546000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661604001238"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,9]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2004,9]]}},"alternative-id":["S1521661604001238"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2004.04.010","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2004,9]]}}}